Navigation Links
TPI Signs Macrolide API International Sales and Marketing Agreement
Date:6/15/2011

CHENGDU, China, June 15, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients (API) today announced that the signing of the sales and marketing agreement with RELATIONS International Ltd., a Bangladesh corporation that specializes in the API sales for its Azithromycin API product sales in the People’s Republic of Bangladesh. “The signing of the agreement demonstrates our effort in further developing our macrolide antibiotic API business internationally,” said Dr. Jiang, Chairman and CEO of TPI.

TPI forecasts $30 million domestic Azithromycin API revenue in China for the first year of operation from its Jiangchuan macrolide facility (JCM) that has an annual manufacturing capacity of 250 tons. The international sales revenue from macrolide API is expected to contribute additional revenue for TPI.

Currently the JCM's license for manufacturing Azithromycin API is active (H10970072). Additional information regarding JCM can be found at www.sfda.gov.cn (Chinese version).

About TPIHeadquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and active pharmaceutical ingredients (API). TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit: http://www.tianyinpharma.com

About RELATIONS International Ltd.RELATIONS International Ltd. (RELATIONS), founded in 1978, incorporated in the People's Republic of Bangladesh, is located at Motijheel Commercial Area, Dhaka-1000, Bangladesh. It specializes in the sales of APIs and other medical/pharmaceutical products in Bangladesh. RELATIONS client base includes Sandoz - Austria, Spain, Italy, Germany & India, Sifavitor, ABC Farmaceutici, Solmag, Recordati, SIMS, Farchemia and Archimia etc of Italy, Kirsch, CF Budenheim, Peter-Greven of Germany, Viscose Closures of UK, Fuji Kasei, Kyowa Hakko and Kaneka of Japan. RELATIONS also established a number of business relations with Chinese manufactures including TPI.

Safe Harbor StatementThe Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.For more information, please visit: http://www.tianyinpharma.com, or email ir@tianyinpharma.comTel:
+86-28-8551-6696 (Chengdu, China)+86-134-3655-0011 (China)Address: Tianyin Pharmaceutical23rd Floor, Unionsun Yangkuo PlazaNo. 2, Block 3, South Renmin RoadChengdu, 610041China
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes
2. Hope Paige Designs Medical ID Bracelets Now Available in 1,100 Additional Locations
3. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
4. Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys
5. Zen Holding Corp. Signs LOI to Acquire Millennium Healthcare Solutions Inc.
6. AccessClosure Signs Distribution Agreement to Enter Into UK, Switzerland and France
7. Governor Daniels Signs Into Law Electronic Tracking Bill
8. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
9. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
10. Digital Assent Signs 100th PatientPad® Customer
11. Sysmex America Signs Distributorship Agreement With LABSCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):